Xeris Biopharma Holdings, Inc.
HealthcareNASDAQ:XERS · NASDAQ Global Select
-$0.14 today
Vol 1.63M · Avg 1.63M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+56.09%
Period High
$9.90
Period Low
$4.35
Latest
$6.79
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Vera Therapeutics, Inc.
NASDAQ:VERA
$2.46B
Celldex Therapeutics, Inc.
NASDAQ:CLDX
$2.08B
Harmony Biosciences Holdings, Inc.
NASDAQ:HRMY
$1.99B
BioCryst Pharmaceuticals, Inc.
NASDAQ:BCRX
$1.83B
Sionna Therapeutics, Inc.
NASDAQ:SION
$1.62B
AbCellera Biologics Inc.
NASDAQ:ABCL
$1.60B
Immunocore Holdings plc
NASDAQ:IMCR
$1.47B
Maze Therapeutics, Inc.
NASDAQ:MAZE
$1.33B
Biohaven Ltd.
NYSE:BHVN
$1.19B
Janux Therapeutics, Inc.
NASDAQ:JANX
$826.95M
What is the latest XERS filing?
The latest filing shown is 8-K dated Jun 11, 2026.
How many recent filings does XERS have?
Intrinsic Alpha currently shows 20 recent filings for XERS.
Explore More
Continue the stock analysis
Jump to another research area for this company.